Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.

MLA

Koss, Catherine A., et al. “Risk Factors for Preterm Birth among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 67, no. 2, Oct. 2014, pp. 128–35. EBSCOhost, https://doi.org/10.1097/QAI.0000000000000281.

APA

Koss, C. A., Natureeba, P., Plenty, A., Luwedde, F., Mwesigwa, J., Ades, V., Charlebois, E. D., Clark, T. D., Achan, J., Ruel, T., Nzarubara, B., Kamya, M. R., Havlir, D. V., & Cohan, D. (2014). Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999), 67(2), 128–135. https://doi.org/10.1097/QAI.0000000000000281

Chicago

Koss, Catherine A, Paul Natureeba, Albert Plenty, Flavia Luwedde, Julia Mwesigwa, Veronica Ades, Edwin D Charlebois, et al. 2014. “Risk Factors for Preterm Birth among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy.” Journal of Acquired Immune Deficiency Syndromes (1999) 67 (2): 128–35. doi:10.1097/QAI.0000000000000281.